Journal: Briefings in Functional Genomics
Article Title: Effect of EGR1/LIPT1 regulatory axis on cuproptosis in chromophobe renal cell carcinoma
doi: 10.1093/bfgp/elaf023
Figure Lengend Snippet: Verification of EGR1’s ability to transcriptionally activate LIPT1. (A) hTFtarget predicted potential upstream TFs of LIPT1. (B) Bioinformatics analysis analyzed Pearson correlation between EGR1 and LIPT1. (C) EGR1 expression levels in chRCC tissues in TCGA database. (D) TASPAR predicted binding sites for EGR1 and LIPT1. (E) qPCR verified transfection efficiency ( n = 3 per group). (F) Dual-luciferase assay verified the binding relationship between EGR1 and LIPT1 ( n = 3 per group). (G) The CHIP experiment verified the target binding relationship between EGR1 and LIPT1 ( n = 3 per group). (H) qPCR was used to detect the content of LIPT1 mRNA in both groups ( n = 3 per group). (I) WB test was used to detect the expression of LIPT1 protein in the two groups ( n = 3 per group). ns indicates no significant difference; * indicates P < 0.05.
Article Snippet: Quantitative polymerase chain reaction (qPCR) was conducted on cDNA, with SYBR Green qPCR detection kit (Toyobo, Japan) used and β-actin as the reference gene.
Techniques: Expressing, Binding Assay, Transfection, Luciferase